India Glycols Intrinsic Value
India Glycols (INDIAGLYCO) median intrinsic value is ₹1364.00 from 9 valuation models (range ₹349–₹2157), vs current price ₹1000.80 — +36.3% upside (Trading Below Calculated Value), margin of safety 26.6%. Browse INDIAGLYCO complete financial statements for revenue, profit, balance sheet and cash flow data.
INDIAGLYCO Valuation Methods Summary — DCF, Graham Number & P/E
India Glycols intrinsic value across 9 models vs current price ₹1000.80 — upside/downside and value range per method. For current market price and key ratios, visit INDIAGLYCO share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1364.00 | ₹1091.20 - ₹1636.80 | +36.3% | EPS: ₹54.56, Sector P/E: 25x |
| Book Value Method | asset | ₹2156.62 | ₹1940.96 - ₹2372.28 | +115.5% | Book Value/Share: ₹862.65, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹1747.06 | ₹1572.35 - ₹1921.77 | +74.6% | Revenue/Share: ₹1164.71, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹2001.60 | ₹1801.44 - ₹2201.76 | +100.0% | EBITDA: ₹720.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹1446.23 | ₹1156.98 - ₹1735.48 | +44.5% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹349.18 | ₹314.26 - ₹384.10 | -65.1% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹1011.54 | ₹910.39 - ₹1112.69 | +1.1% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹1228.24 | ₹1105.42 - ₹1351.06 | +22.7% | ROE: 11.9%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹1029.07 | ₹926.16 - ₹1131.98 | +2.8% | EPS: ₹54.56, BVPS: ₹862.65 |
INDIAGLYCO Intrinsic Value vs Market Price — All Valuation Models
India Glycols fair value range ₹349–₹2157 vs current market price ₹1000.80 across 9 valuation models. Also explore INDIAGLYCO share price data to track price trends across different timeframes.
INDIAGLYCO Intrinsic Value Analysis — Undervalued or Overvalued?
India Glycols median intrinsic value ₹1364.00, current price ₹1000.80 — Trading Below Calculated Value by 36.3%, margin of safety 26.6%.
What is the intrinsic value of INDIAGLYCO?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of India Glycols (INDIAGLYCO) is ₹1364.00 (median value). With the current market price of ₹1000.80, this represents a +36.3% variance from our estimated fair value.
The valuation range spans from ₹349.18 to ₹2156.62, indicating ₹349.18 - ₹2156.62.
Is INDIAGLYCO undervalued or overvalued?
Based on our multi-method analysis, India Glycols (INDIAGLYCO) appears to be trading below calculated value by approximately 36.3%.
INDIAGLYCO Financial Health — Key Ratios vs Industry Benchmarks
India Glycols financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.95 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 11.9% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.61x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
INDIAGLYCO Cash Flow Quality — Operating & Free Cash Flow
India Glycols operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹362 Cr | ₹-6 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹439 Cr | ₹187 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹326 Cr | ₹161 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹116 Cr | ₹116 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹137 Cr | ₹63 Cr | Positive Free Cash Flow | 7/10 |